Coherent Financial Statements (COHR)

Coherentsmart-lab.ru %   2022 2022 2023 2023 2024   LTM ?
Report date 31.12.2022 08.02.2023 30.06.2023 18.08.2023 16.08.2024   06.11.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 5 160 5 160 4 708   3 967
Operating Income, bln rub 50.4 50.4 123.2   -31 577
EBITDA, bln rub ? 50.4 613.0 700.6   752.3
Net profit, bln rub ? -259.5 -259.5 -279.5   91.0
OCF, bln rub ? 634.0 634.0 545.7   153 260
CAPEX, bln rub ? 436.1 436.1 346.8   92 177
FCF, bln rub ? 198.0 198.0 198.9   61 083
Dividend payout, bln rub 27.6 27.6 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
Dividend payout ratio, % 0.00% 0.00% 0.00%   0
OPEX, bln rub 1 536 1 536 1 456   1 048
Cost of production, bln rub 3 542 3 542 3 252   2 613
R&D, bln rub 499.6 499.6 478.8   386.1
Interest expenses, bln rub 286.9 286.9 288.5   260.5
Assets, bln rub 14 109 14 109 13 711 13 711 14 489   14 699 300
Net Assets, bln rub ? 2 182 2 182 4 988 4 988 7 575   5 501 077
Debt, bln rub 4 683 4 683 4 489 4 489 4 303   4 207 101
Cash, bln rub 913.3 913.3 833.3 833.3 926.0   1 019 648
Net debt, bln rub 3 770 3 770 3 655 3 655 3 377   3 187 453
Ordinary share price, rub 35.1 35.1 51.0 51.0 72.5   31.0
Number of ordinary shares, mln 137.6 137.6 151.6   151.6
Market cap, bln rub 0 0 7 014 7 014 10 988   4 701
EV, bln rub ? 3 770 3 770 10 669 10 669 14 365   3 192 154
Book value, bln rub -6 273 -6 273 -3 340 -3 340 -393   -2 609 253
EPS, rub ? -1.89 -1.89 -1.84   0.60
FCF/share, rub 1.44 1.44 1.31   402.8
BV/share, rub -24.3 -24.3 -2.59   -17 207
EBITDA margin, % ? 0.98% 11.9% 14.9%   19.0%
Net margin, % ? -5.03% -5.03% -5.94%   2.29%
FCF yield, % ? 0.00% 0.00% 2.82% 2.82% 1.81%   1 299%
ROE, % ? 0.00% 0.00% -5.20% -5.20% -3.69%   0.00%
ROA, % ? 0.00% 0.00% -1.89% -1.89% -1.93%   0.00%
P/E ? -27.0 -27.0 -39.3   51.7
P/FCF 35.4 35.4 55.2   0.08
P/S ? 1.36 1.36 2.33   1.18
P/BV ? 0.00 0.00 -2.10 -2.10 -28.0   0.00
EV/EBITDA ? 211.6 17.4 20.5   4 243
Debt/EBITDA 72.5 5.96 4.82   4 237
R&D/CAPEX, % 114.6% 114.6% 138.1%   0.42%
CAPEX/Revenue, % 8.45% 8.45% 7.37%   2 324%
Coherent shareholders